Key points are not available for this paper at this time.
In a large, claims-based analysis, we did not find an increased risk of breast cancer recurrence within 5 years in women with a personal history of breast cancer who were using vaginal estrogen for genitourinary syndrome of menopause.
Agrawal et al. (Thu,) studied this question.